1. Home
  2. BCHT vs NNVC Comparison

BCHT vs NNVC Comparison

Compare BCHT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birchtech Corp. Common Stock

BCHT

Birchtech Corp. Common Stock

N/A

Current Price

$1.38

Market Cap

36.6M

Sector

Industrials

ML Signal

N/A

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.02

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCHT
NNVC
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.6M
35.2M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
BCHT
NNVC
Price
$1.38
$1.02
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
68.3K
261.9K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.00
EPS
N/A
N/A
Revenue
$17,626,366.00
N/A
Revenue This Year
$13.42
N/A
Revenue Next Year
$61.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.26
N/A
52 Week Low
$1.14
$0.85
52 Week High
$2.48
$2.23

Technical Indicators

Market Signals
Indicator
BCHT
NNVC
Relative Strength Index (RSI) 51.97 19.26
Support Level $1.26 $0.86
Resistance Level $1.54 $1.07
Average True Range (ATR) 0.07 0.06
MACD 0.02 -0.02
Stochastic Oscillator 75.00 2.26

Price Performance

Historical Comparison
BCHT
NNVC

About BCHT Birchtech Corp. Common Stock

Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: